These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19398164)

  • 1. Illicit use of pharmaceutical opioids among young polydrug users in Ohio.
    Daniulaityte R; Falck RS; Wang J; Carlson RG
    Addict Behav; 2009 Aug; 34(8):649-53. PubMed ID: 19398164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis.
    Carlson RG; Wang J; Falck RS; Siegal HA
    Drug Alcohol Depend; 2005 Aug; 79(2):167-79. PubMed ID: 16002026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Keyes KM; Martins SS; Hasin DS
    Drug Alcohol Depend; 2008 Sep; 97(1-2):139-49. PubMed ID: 18524499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The variety of ecstasy/MDMA users: results from the National Epidemiologic Survey on alcohol and related conditions.
    Wu LT; Parrott AC; Ringwalt CL; Yang C; Blazer DG
    Am J Addict; 2009; 18(6):452-61. PubMed ID: 19874166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of, and Factors Associated With, Illicit Pharmaceutical Opioid Analgesic Use in a Prospective Cohort of People Who Inject Drugs in Melbourne, Australia.
    Horyniak D; Agius PA; Degenhardt L; Reddel S; Higgs P; Aitken C; Stoové M; Dietze P
    Subst Use Misuse; 2015; 50(13):1650-9. PubMed ID: 26576630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for significant polydrug use among ecstasy-using college students.
    Wish ED; Fitzelle DB; O'Grady KE; Hsu MH; Arria AM
    J Am Coll Health; 2006; 55(2):99-104. PubMed ID: 17017306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids.
    Daniulaityte R; Falck R; Carlson RG
    Drug Alcohol Depend; 2012 May; 122(3):201-7. PubMed ID: 22036303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent class analysis of non-opioid dependent illegal pharmaceutical opioid users in Ohio.
    Carlson RG; Nahhas RW; Daniulaityte R; Martins SS; Li L; Falck R
    Drug Alcohol Depend; 2014 Jan; 134():259-266. PubMed ID: 24210772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The external validity of results derived from ecstasy users recruited using purposive sampling strategies.
    Topp L; Barker B; Degenhardt L
    Drug Alcohol Depend; 2004 Jan; 73(1):33-40. PubMed ID: 14687957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-medical use of pharmaceutical opioids with and without other illicit substances in Australia: Prevalence and correlates.
    Chan GCK; Leung J; Hall W
    Drug Alcohol Rev; 2019 Feb; 38(2):151-158. PubMed ID: 30652366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sources of pharmaceutical opioids for non-medical use among young adults.
    Daniulaityte R; Falck R; Carlson RG
    J Psychoactive Drugs; 2014; 46(3):198-207. PubMed ID: 25052878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): Implications for risk reduction.
    Rigg KK; Sharp A
    Addict Behav; 2018 Apr; 79():159-165. PubMed ID: 29291506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic.
    Faller RW; Erausquin JT; McCoy TP
    Subst Use Misuse; 2021; 56(2):333-337. PubMed ID: 33325317
    [No Abstract]   [Full Text] [Related]  

  • 14. Tri-city study of Ecstasy use problems: a latent class analysis.
    Scheier LM; Ben Abdallah A; Inciardi JA; Copeland J; Cottler LB
    Drug Alcohol Depend; 2008 Dec; 98(3):249-63. PubMed ID: 18674872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients.
    Manchikanti L; Giordano J; Boswell MV; Fellows B; Manchukonda R; Pampati V
    J Opioid Manag; 2007; 3(2):89-100. PubMed ID: 17520988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "I'm not afraid of those ones just 'cause they've been prescribed": perceptions of risk among illicit users of pharmaceutical opioids.
    Daniulaityte R; Falck R; Carlson RG
    Int J Drug Policy; 2012 Sep; 23(5):374-84. PubMed ID: 22417823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and correlates of current depressive symptomatology among a community sample of MDMA users in Ohio.
    Falck RS; Wang J; Carlson RG; Siegal HA
    Addict Behav; 2006 Jan; 31(1):90-101. PubMed ID: 15922511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G; Van Dam NT; Redman J
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
    Ogeil RP; Rajaratnam SM; Broadbear JH
    Drug Alcohol Depend; 2013 Sep; 132(1-2):223-30. PubMed ID: 23453259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.